Page last updated: 2024-11-06

2-nitropropanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Nitropropanol is a colorless to pale yellow liquid with a characteristic odor. It is an important intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. Its synthesis involves the nitration of propanol with nitric acid in the presence of a catalyst. It is known to be a potent vasodilator and has been investigated for its potential therapeutic applications in cardiovascular disease. Research on 2-nitropropanol focuses on its biological activity, its role in the synthesis of other compounds, and its potential environmental impact.'

2-nitropropanol: has antimicrobial activity; a cross-linking reagent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92187
CHEBI ID139383
SCHEMBL ID524448
SCHEMBL ID17066395
MeSH IDM0480837

Synonyms (29)

Synonym
nsc16159
2-nitropropanol-1
2902-96-7
ba 51-084789
2-nitro-1-propanol
nsc-16159
2-nitropropanol
1-propanol, 2-nitro-
2-nitro-1-propanol, >=95%
nsc 16159
2-nitropropan-1-ol
einecs 220-797-0
ccris 5045
CHEBI:139383
AKOS006222515
FT-0634544
AKOS015912903
2-nitro-propan-1-ol
SCHEMBL524448
SCHEMBL17066395
2-nitro-1-propanol, purum, >=97.0% (gc)
mfcd00007398
J-017359
DTXSID60863052
CS-0204482
AS-10655
EN300-201674
SB84187
AT35066

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The most toxic of the group was 2-nitro-1-propanol."( Short chain aliphatic beta-nitro alcohols for corneoscleral cross-linking: corneal endothelial toxicity studies.
Braunstein, RE; Paik, DC; Trokel, SL; Wen, Q, 2008
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
" In the present study, the circular bacteriocin enterocin AS-48, applied singly or in combination with phenolic compounds (carvacrol, eugenol, geraniol, and citral) or with 2-nitro-1-propanol (2NPOH), was investigated in the control of a cocktail made from 1 methicillin-sensitive and 1 MRSA strains inoculated on commercial oat and soya drinks."( Inactivation of Staphylococcus aureus in Oat and Soya Drinks by Enterocin AS-48 in Combination with Other Antimicrobials.
Aguayo, MC; Burgos, MJ; Gálvez, A; López, RL; Pulido, RP, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" Moreover, an interaction between challenge and linear dosage effects was observed for IDE (P = 0."( 2-Nitro-1-propanol improved nutrient digestibility and oocyst shedding but not growth performance of Eimeria-challenged broilers.
Dos Santos, TS; Fuller, AL; Kim, WK; Teng, PY; Yadav, S, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (37.50)29.6817
2010's7 (43.75)24.3611
2020's3 (18.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.31 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]